Ixaka expands IP portfolio to allow use of TNP gene delivery platform across multiple areas March 21, 2022
Series A financing at Scenic Biotech to support immuno-oncology and rare inherited disease pipeline March 10, 2022
Novel UV-mediated antigen-presenting nanoparticles for mRNA delivery to virus-specific T cells March 7, 2022
eTheRNA and Merck KGaA sign research agreement to assess mRNA technology for therapeutic vaccination Feb. 7, 2022
RSS